MALI
MALI Platform
AI Stock Research

a16z Capital Management, L.L.C.: latest 13F holdings

For the quarter ending 30 September 2026, a16z Capital Management, L.L.C. reported 24 positions worth $19.9B in total, filed with the SEC on 16 November 2026. The quarter before, it reported $14.2B.

Read the filing at SEC EDGAR
Checked: the cover page's entry count and total value match the holdings table.

Top 24 positions by value

#IssuerClassValueWeightSharesvs quarter before
1SPACE EXPLORATION TECHN CORPCLASS A COM STK$18.4B92.35%121,777,808Added 62.7%
2NAVAN INCCL A$592.3M2.98%28,218,676Unchanged
3BRAVEHEART BIO INCCOM SHS$206.7M1.04%10,232,420New
4REVOLUTION MEDICINES INCCOM$160.7M0.81%782,934Cut 15.0%
5FREENOME INCCOMMON STOCK$87.8M0.44%5,571,599New
6NEUTRON HOLDINGS INCCOM$80.3M0.40%2,849,097New
7BLOCK INCCL A$74.8M0.38%1,016,697Unchanged
8SCRIBE THERAPEUTICS INCCOM$56.7M0.29%3,082,725New
9FIGMA INCCLASS A COM STK$53.9M0.27%2,565,731Cut 57.1%
10MAZE THERAPEUTICS INCCOM$46.3M0.23%1,702,225Unchanged
11STANDARD NUCLEAR INCCOM CL A$34.5M0.17%2,924,890New
12DAMORA THERAPEUTICS INCCOM NEW$26.3M0.13%1,236,157Unchanged
13BIOAGE LABS INCCOM$22.9M0.12%3,233,170Unchanged
14ERASCA INCCOM$21.0M0.11%1,431,250Cut 50.0%
15META PLATFORMS INCCL A$15.2M0.08%20,951Cut 90.1%
16ROBLOX CORPCL A$11.6M0.06%274,570Unchanged
17CAMP4 THERAPEUTICS CORPCOM$8.6M0.04%2,125,339Unchanged
18AKTIS ONCOLOGY INCCOM$8.1M0.04%415,000Unchanged
19BITGO HOLDINGS INCCOM SHS CL A$4.9M0.02%666,356Unchanged
20NAUTILUS BIOTECHNOLOGY INCCOM$3.8M0.02%2,656,655Cut 70.7%
21BLOSSOMHILL THERAPEUTICS INCCOM$2.3M0.01%125,000New
22KAILERA THERAPEUTICS INCCOMMON STOCK$1.6M0.01%140,000Unchanged
23GINKGO BIOWORKS HOLDINGS INCCL A NEW$1.4M0.01%108,568Unchanged
24IP STRATEGY HOLDINGS INCCOM$13.2K0.00%4,137Unchanged

New this quarter

  • BRAVEHEART BIO INC · $206.7M
  • FREENOME INC · $87.8M
  • NEUTRON HOLDINGS INC · $80.3M
  • SCRIBE THERAPEUTICS INC · $56.7M
  • STANDARD NUCLEAR INC · $34.5M
  • BLOSSOMHILL THERAPEUTICS INC · $2.3M

Sold out

  • OMADA HEALTH INC · was $25.3M

Reading a 13F

A 13F lists a manager's long positions in US-listed securities at the end of a quarter, filed up to 45 days later. It leaves out short positions, cash and most non-US holdings, so it is a partial, delayed view of a portfolio. Nothing here is investment advice.

Positions are named as the manager filed them. Values are the filing's own, in US dollars; changes compare share counts with the quarter before.

Other managers